Most Recent
The lead applicant in a Maurice Blackburn-led class action against superannuation provider Colonial First State wants the Full Court to determine whether group members still have valid claims, after a judgment from the Victoria Supreme Court shut down a similar class action last year.
The Commonwealth says a landmark ruling in a class action that found it has a duty of care to protect Australian children from the effects of global warming is "incoherent" and distorts its ability to balance competing interests.
An appeals court has upheld a $100,000 sexual harassment judgment against a Sanitarium-owned company for designing, displaying and distributing a poster featuring a worker alongside the words "feel great - lubricate".
With $254 million at stake, Westpac wants a court order blocking the business partner of Forum Group founder Bill Papas from leaving Australia, as Papas remains in Greece while fraud allegations swirl.
Noting that the legal costs of a dispute over whether she could represent federal minister Christian Porter in his defamation case were "substantial", Sue Chrysanthou SC has asked to see invoices before she agrees to a lump sum bill of $550,000.
ISignthis CEO John Karantzis has filed court proceedings against the ATO seeking to have $4.2 million lopped off his tax bill for the 2015 financial year.
Thorn Group is the latest lender ensnared in an alleged $400 million fraud by Forum Finance, with potential funds of up to $2.2 million tied up in the collapsed equipment leasing firm.
Melbourne-based joint venture Shepparton Partners Collective has appealed a $1.2 million judgment which found it infringed software developer QAD's copyright by failing to pay a transfer fee to retain the licence after it acquired the iconic SPC Ardmona cannery in Victoria from Coca-Cola Amatil for $40 million.
Four witnesses who allegedly saw Ben Roberts-Smith kick a handcuffed man off a cliff in Afghanistan will give evidence next week in the war veteran’s defamation trial, which has been disrupted by COVID-19 restrictions in NSW.
Merck Sharp & Dohme has filed a lawsuit accusing rival drug company Bristol-Myers Squibb of misusing its market power by restricting access to a treatment program for stage IV melanoma patients.